HDAC9 and acute lymphoblastic leukemia: Despite markedly heterogeneous therapeutic effects, HDAC inhibition occurred in all samples, as shown by western blotting analysis of the acetylated form of α-tubulin in T-ALL cells from the spleen of mice representative of each group (Figure 1c).